Go Pro

Zentalis Pharmaceuticals (ZNTL) Institutional Ownership

Zentalis Pharmaceuticals logo
$4.46 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$4.56 +0.10 (+2.24%)
As of 07/2/2026 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Zentalis Pharmaceuticals (NASDAQ:ZNTL)

Number of
Institutional Buyers
(last 12 months)
50
Total
Institutional Inflows
(last 12 months)
$19.51M
Number of
Institutional Sellers
(last 12 months)
33
Total
Institutional Outflows
(last 12 months)
$15.73M
Get ZNTL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Zentalis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ZNTL Institutional Buying and Selling by Quarter

Zentalis Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/4/2026Seven Fleet Capital Management LP110,000$257K0.1%N/A0.155%
5/21/2026CTC Alternative Strategies Ltd.12,500$29K0.1%N/A0.018%
5/19/2026Bank of America Corp DE1,132,294$2.65M0.0%-17.2%1.591%
5/19/2026RBF Capital LLC50,000$117K0.0%-37.5%0.070%
5/18/2026ADAR1 Capital Management LLC144,636$338K0.0%+80.8%0.203%
5/15/2026OMERS ADMINISTRATION Corp47,700$112K0.0%N/A0.067%
5/14/2026Renaissance Technologies LLC1,938,145$4.54M0.0%-32.8%2.723%
5/14/2026Sei Investments Co.191,551$448K0.0%+14.6%0.269%
5/14/2026State of Wyoming28,466$67K0.0%N/A0.040%
5/7/2026Dimensional Fund Advisors LP272,034$634K0.0%+182.6%0.382%
4/27/2026Private Advisor Group LLC31,472$74K0.0%N/A0.044%
2/19/2026Invesco Ltd.188,582$255K0.0%+8.6%0.261%
2/18/2026XTX Topco Ltd576,707$779K0.0%+5.1%0.798%
2/18/2026Quadrature Capital Ltd137,568$186K0.0%+126.8%0.190%
2/18/2026Opaleye Management Inc.1,400,906$1.89M0.2%+342.6%1.939%
2/18/2026Millennium Management LLC673,129$909K0.0%-25.4%0.932%
2/18/2026Ishara Investments LP1,320,000$1.78M2.1%N/A1.827%
2/18/20265AM Venture Management LLC3,947,913$5.33M1.7%+705.7%5.464%
2/17/2026ADAR1 Capital Management LLC80,000$108K0.0%+60.0%0.111%
2/17/2026Almitas Capital LLC610,073$824K0.2%+33.4%0.844%
2/17/2026AQR Capital Management LLC45,995$62K0.0%-57.0%0.064%
2/17/2026Graham Capital Management L.P.90,910$123K0.0%-40.2%0.126%
2/17/2026Opal Capital LLC72,251$98K0.0%N/A0.100%
2/16/2026Squarepoint Ops LLC107,734$145K0.0%+405.3%0.149%
2/16/2026Panagora Asset Management Inc.86,640$117K0.0%-11.5%0.120%
2/16/2026Barclays PLC568,443$767K0.0%+252.0%0.787%
2/13/2026Marshall Wace LLP247,788$335K0.0%N/A0.343%
2/13/2026Walleye Capital LLC110,448$149K0.0%-8.3%0.153%
2/13/2026Quarry LP132,000$178K0.0%+21.4%0.183%
2/12/2026Jane Street Group LLC473,175$639K0.0%-26.7%0.655%
2/12/2026Carson Advisory Inc.23,470$32K0.0%-26.8%0.032%
2/12/2026Renaissance Technologies LLC2,883,745$3.89M0.0%+24.0%3.991%
2/12/2026Dimensional Fund Advisors LP96,263$130K0.0%-48.0%0.133%
2/12/2026Federated Hermes Inc.34,574$47K0.0%-15.9%0.048%
2/11/2026Primecap Management Co. CA957,420$1.29M0.0%-0.5%1.325%
2/10/2026Sivia Capital Partners LLC20,000$27K0.0%N/A0.028%
2/10/2026Goldman Sachs Group Inc.118,212$160K0.0%-65.8%0.164%
2/6/2026GSA Capital Partners LLP1,169,573$1.58M0.1%+8.5%1.619%
2/5/2026Barr E S & Co.57,500$78K0.0%+43.8%0.080%
2/4/202649 Wealth Management LLC70,911$96K0.0%+151.5%0.098%
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
2/3/2026Anfield Capital Management LLC242,605$328K0.1%+239.9%0.336%
1/28/2026Peapod Lane Capital LLC448,861$606K0.5%-20.6%0.621%
1/8/2026Wealth Enhancement Advisory Services LLC130,407$176K0.0%-21.6%0.180%
1/1/2026JPMorgan Chase & Co.723,075$1.09M0.0%+31.4%1.001%
11/17/2025Jacobs Levy Equity Management Inc.700,576$1.06M0.0%-18.3%0.970%
11/17/2025XTX Topco Ltd548,629$828K0.0%+107.2%0.759%
11/17/2025Voleon Capital Management LP27,161$41K0.0%N/A0.038%
11/17/2025Qube Research & Technologies Ltd56,639$86K0.0%+76.4%0.078%
11/17/2025Millennium Management LLC902,521$1.36M0.0%-74.0%1.249%
11/17/2025Bank of America Corp DE1,548,781$2.34M0.0%+117.1%2.144%
11/17/2025Almitas Capital LLC457,322$691K0.2%-71.4%0.633%
11/17/2025Algert Global LLC48,496$73K0.0%N/A0.067%
11/17/2025Ameriprise Financial Inc.52,572$79K0.0%-42.4%0.073%
11/14/2025Creative Planning260,000$393K0.0%+757.0%0.360%
11/14/2025Two Sigma Investments LP1,363,347$2.06M0.0%+24.7%1.887%
11/14/2025Squarepoint Ops LLC21,322$32K0.0%-54.1%0.030%
11/13/2025UBS Group AG532,678$804K0.0%+311.4%0.738%
11/13/2025BNP Paribas Financial Markets158,935$240K0.0%-8.4%0.220%
11/12/2025Dimensional Fund Advisors LP185,032$279K0.0%-44.9%0.256%
11/12/2025Primecap Management Co. CA962,620$1.45M0.0%-6.3%1.334%
11/7/2025GSA Capital Partners LLP1,077,656$1.63M0.1%-4.9%1.494%
11/7/2025Vanguard Group Inc.2,904,400$4.39M0.0%+0.7%4.026%
11/7/2025JPMorgan Chase & Co.723,075$1.09M0.0%+31.4%1.002%
11/6/2025Tybourne Capital Management HK Ltd.961,486$1.45M4.7%-35.0%1.333%
11/5/2025Savant Capital LLC16,521$25K0.0%-67.4%0.023%
10/29/2025Wealth Enhancement Advisory Services LLC166,290$258K0.0%-4.4%0.231%
10/23/2025SG Americas Securities LLC31,579$48K0.0%+35.3%0.044%
9/26/2025Corient Private Wealth LLC35,760$41K0.0%N/A0.050%
8/19/2025State of Wyoming73,797$86K0.0%+63.4%0.102%
8/15/2025Corient Private Wealth LLC71,520$83K0.0%N/A0.099%
8/15/2025Opaleye Management Inc.1,924,300$2.23M0.5%-3.1%2.667%
8/15/2025Man Group plc406,344$471K0.0%+302.3%0.563%
8/15/2025BNP Paribas Financial Markets173,484$201K0.0%+145.0%0.240%
8/15/2025Bridgeway Capital Management LLC77,300$90K0.0%-49.2%0.107%
8/15/2025Balyasny Asset Management L.P.970,862$1.13M0.0%N/A1.346%
8/15/2025Bank of America Corp DE713,315$827K0.0%-36.9%0.989%
8/15/2025Ameriprise Financial Inc.91,195$106K0.0%+622.8%0.126%
8/14/2025Jane Street Group LLC664,061$770K0.0%+346.3%0.921%
8/14/2025Sei Investments Co.167,100$194K0.0%+373.1%0.232%
8/14/2025RBF Capital LLC80,000$93K0.0%N/A0.111%
8/14/2025Qube Research & Technologies Ltd32,113$37K0.0%N/A0.045%
8/14/2025Federated Hermes Inc.39,736$46K0.0%-94.7%0.055%
8/13/2025Walleye Capital LLC129,867$151K0.0%-62.0%0.180%
8/13/2025Decheng Capital LLC1,323,327$1.54M0.4%-34.5%1.834%
8/13/2025Stonepine Capital Management LLC109,010$126K0.1%+81.7%0.151%
8/13/2025Quadrature Capital Ltd52,456$61K0.0%N/A0.073%
8/12/2025XTX Topco Ltd264,829$307K0.0%+112.9%0.367%
8/12/2025JPMorgan Chase & Co.550,447$639K0.0%-26.3%0.763%
8/12/2025Catalyst Funds Management Pty Ltd26,800$31K0.0%N/A0.037%
8/11/2025Primecap Management Co. CA1,027,620$1.19M0.0%-18.7%1.428%
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
8/8/2025Creative Planning30,340$35K0.0%-87.2%0.042%
8/8/2025Geode Capital Management LLC618,167$717K0.0%-54.4%0.859%
8/7/202549 Wealth Management LLC21,546$25K0.0%-52.7%0.030%
8/7/2025Acadian Asset Management LLC2,799,020$3.24M0.0%+4.7%3.890%
8/7/2025Connor Clark & Lunn Investment Management Ltd.314,845$365K0.0%-12.8%0.438%
8/6/2025Savant Capital LLC50,727$59K0.0%N/A0.071%
8/1/2025Y Intercept Hong Kong Ltd32,740$38K0.0%N/A0.046%
8/1/2025Tybourne Capital Management HK Ltd.1,478,152$1.72M5.0%+53.7%2.054%
7/25/2025CWM LLC28,646$33K0.0%-27.8%0.040%
7/15/2025Public Employees Retirement System of Ohio36,700$43K0.0%+351.7%0.051%


ZNTL Institutional Ownership - Frequently Asked Questions

During the previous two years, 128 institutional investors and hedge funds held shares of Zentalis Pharmaceuticals. The most heavily invested institutionals were FMR LLC ($18.68M), Verition Fund Management LLC ($5.54M), 5AM Venture Management LLC ($5.33M), State Street Corp ($4.59M), Renaissance Technologies LLC ($4.54M), Vanguard Group Inc. ($4.39M), and D. E. Shaw & Co. Inc. ($3.76M).Learn more on Zentalis Pharmaceuticals' institutional investors.

Of the 113 institutional investors that purchased Zentalis Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: 5AM Venture Management LLC ($3.46M), Millennium Management LLC ($2.18M), Acadian Asset Management LLC ($1.73M), Ishara Investments LP ($1.32M), Opaleye Management Inc. ($1.08M), Integral Health Asset Management LLC ($1.05M), and Balyasny Asset Management L.P. ($970.86K).

Institutional investors have bought a total of 14,269,146 shares in the last 24 months. This purchase volume represents approximately $19.51M in transactions.

Of the 33 institutional investors that sold Zentalis Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($2.80M), Almitas Capital LLC ($1.14M), Renaissance Technologies LLC ($945.60K), Geode Capital Management LLC ($737.50K), Federated Hermes Inc. ($719.33K), Decheng Capital LLC ($696.44K), and Bank of America Corp DE ($651.74K).

Institutional investors have sold a total of 10,717,508 shares in the last 24 months. This volume of shares sold represents approximately $15.73M in transactions.



This page (NASDAQ:ZNTL) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners